Evidence map›Paper›PMID 25395359›Full record

ArticleJournal of lipid research2015

Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.

Mini P Sajan, Robert A Ivey, Mackenzie C Lee, Robert V Farese

Abstract read
In one paragraph

Article in Journal of lipid research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Experimental models in diabetes research.Laboratory animal research · 2026
    Review
  2. Article
  3. Article
  4. Intracellular Sphingosine-1-Phosphate Induces Lipolysis Through Direct Activation of Protein Kinase C Zeta.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.Advances in experimental medicine and biology · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Neutral sphingomyelinase-2 and cardiometabolic diseases.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2021
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mini P SajanMedical and Research Services, James A. Haley Veterans Medical Center, Tampa, FL Division of Endocrinology and Metabolism, Department of Internal Medicine, University of South Florida College of Medicine, Tampa, FL.
Robert A IveyMedical and Research Services, James A. Haley Veterans Medical Center, Tampa, FL.
Mackenzie C LeeMedical and Research Services, James A. Haley Veterans Medical Center, Tampa, FL.
Robert V FareseMedical and Research Services, James A. Haley Veterans Medical Center, Tampa, FL Division of Endocrinology and Metabolism, Department of Internal Medicine, University of South Florida College of Medicine, Tampa, FL.

Funding

Activation of Atypical PKC by Insulin and Other AgonistsR01DK065969 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI FARESE, ROBERT V · 2004 to 2014
$2.8M
Atypical PKC Knockout Models: Effect on Glucose and Lipid HomeostasisI01BX001415 · VA · JAMES A. HALEY VA MEDICAL CENTER · PI FARESE, ROBERT V · 2013 to 2016
–
BLRD VA I01 BX001415NIDDK NIH HHS 7R01 DK 065969-09NIDDK NIH HHS R01 DK065969
6 · The paper itself

Abstract

Pathogenesis of insulin resistance in leptin-deficient ob/ob mice is obscure. In another form of diet-dependent obesity, high-fat-fed mice, hepatic insulin resistance involves ceramide-induced activation of atypical protein kinase C (aPKC), which selectively impairs protein kinase B (Akt)-dependent forkhead box O1 protein (FoxO1) phosphorylation on scaffolding protein, 40 kDa WD(tryp-x-x-asp)-repeat propeller/FYVE protein (WD40/ProF), thereby increasing gluconeogenesis. Resultant hyperinsulinemia activates hepatic Akt and mammalian target of rapamycin C1, and further activates aPKC; consequently, lipogenic enzyme expression increases, and insulin signaling in muscle is secondarily impaired. Here, in obese minimally-diabetic ob/ob mice, hepatic ceramide and aPKC activity and its association with WD40/ProF were increased. Hepatic Akt activity was also increased, but Akt associated with WD40/ProF was diminished and accounted for reduced FoxO1 phosphorylation and increased gluconeogenic enzyme expression. Most importantly, liver-selective inhibition of aPKC decreased aPKC and increased Akt association with WD40/ProF, thereby restoring FoxO1 phosphorylation and reducing gluconeogenic enzyme expression. Additionally, lipogenic enzyme expression diminished, and insulin signaling in muscle, glucose tolerance, obesity, hepatosteatosis, and hyperlipidemia improved. In conclusion, hepatic ceramide accumulates in response to CNS-dependent dietary excess irrespective of fat content; hepatic insulin resistance is prominent in ob/ob mice and involves aPKC-dependent displacement of Akt fromWD40/ProF and subsequent impairment of FoxO1 phosphorylation and increased expression of hepatic gluconeogenic and lipogenic enzymes; and hepatic alterations diminish insulin signaling in muscle.

Indexed as

Insulin ResistanceAnimalsCarrier ProteinsCeramidesCyclopentanesEnzyme ActivationForkhead Box Protein O1Forkhead Transcription FactorsGene Expression RegulationGlucose Tolerance TestGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaLipogenesisLiverMaleMiceCarrier ProteinsCeramidesCyclopentanesForkhead Box Protein O1Forkhead Transcription FactorsFoxo1 protein, mouseGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaPKC-3 proteinProF protein, mouseProtein Kinase CProto-Oncogene Proteins c-aktSphingomyelinsTOR Serine-Threonine Kinasesatypical protein kinase Cceramideforkhead box O1 proteingluconeogenesislipogenesismammalian target of rapamycinobesityprotein kinase Bprotein kinase C-ζprotein kinase C-ιtype 2 diabetes

Identifiers

PMID25395359
PMCPMC4274073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.